# Non-ST Elevation ACS (NSTEMI / Unstable Angina) Management

## Diagnosis
- **NSTEMI**: Elevated troponin with ischemic symptoms and/or ECG changes (ST depression, T-wave inversion)
- **Unstable Angina**: Negative troponin with concerning symptoms (rest pain, crescendo angina, new-onset severe angina)
- ECG: ST depression ≥0.5mm, T-wave inversion ≥1mm, or transient ST elevation

## Risk Stratification
- **TIMI Score** (0-7): Age ≥65, ≥3 CAD risk factors, known CAD (≥50% stenosis), ASA use in last 7 days, ≥2 anginal events in 24hr, ST deviation ≥0.5mm, elevated troponin
  - Low risk (0-2): Conservative strategy may be appropriate
  - Intermediate (3-4): Early invasive strategy preferred
  - High risk (5-7): Early invasive strategy recommended
- **GRACE Score**: More comprehensive, predicts in-hospital and 6-month mortality

## Initial Medical Management
- **Aspirin** 325mg loading, then 81mg daily
- **P2Y12 inhibitor**: Ticagrelor 180mg load → 90mg BID, or Clopidogrel 300-600mg load → 75mg daily
- **Anticoagulation**: Enoxaparin 1mg/kg BID, UFH, fondaparinux, or bivalirudin
- **Beta-blocker**: Metoprolol if no contraindications
- **Nitroglycerin**: Sublingual or IV for ongoing ischemia
- **Statin**: High-intensity statin therapy

## Invasive Strategy
- **Early invasive** (within 24 hours): High-risk features — recurrent angina, hemodynamic instability, sustained VT/VF, elevated troponin, GRACE >140
- **Delayed invasive** (within 25-72 hours): Intermediate risk without high-risk features
- **Ischemia-guided** (conservative): Low-risk, patient preference, comorbidities

## Discharge and Follow-Up
- DAPT: 12 months (may shorten to 6 months or extend to 36 months based on bleeding/ischemic risk)
- Cardiac rehabilitation
- Echocardiogram if new HF suspected
- Follow-up within 2 weeks
